157 related articles for article (PubMed ID: 23830988)
21. Characterization of Pb51 in Plasmodium berghei as a malaria vaccine candidate targeting both asexual erythrocytic proliferation and transmission.
Wang J; Zheng W; Liu F; Wang Y; He Y; Zheng L; Fan Q; Luo E; Cao Y; Cui L
Malar J; 2017 Nov; 16(1):458. PubMed ID: 29132428
[TBL] [Abstract][Full Text] [Related]
22. A role of falcipain-2, principal cysteine proteases of Plasmodium falciparum in merozoite egression.
Dasaradhi PV; Mohmmed A; Kumar A; Hossain MJ; Bhatnagar RK; Chauhan VS; Malhotra P
Biochem Biophys Res Commun; 2005 Nov; 336(4):1062-8. PubMed ID: 16165088
[TBL] [Abstract][Full Text] [Related]
23. Plasmodium berghei merozoite surface protein-9: immunogenicity and protective efficacy using a homologous challenge model.
Lopera-Mesa TM; Kushwaha A; Mohmmed A; Chauhan VS
Vaccine; 2008 Mar; 26(10):1335-43. PubMed ID: 18272263
[TBL] [Abstract][Full Text] [Related]
24. Antibody recognition of rodent malaria parasite antigens exposed at the infected erythrocyte surface: specificity of immunity generated in hyperimmune mice.
Mota MM; Brown KN; Do Rosário VE; Holder AA; Jarra W
Infect Immun; 2001 Apr; 69(4):2535-41. PubMed ID: 11254617
[TBL] [Abstract][Full Text] [Related]
25. Falcipain cysteine proteases of malaria parasites: An update.
Rosenthal PJ
Biochim Biophys Acta Proteins Proteom; 2020 Mar; 1868(3):140362. PubMed ID: 31927030
[TBL] [Abstract][Full Text] [Related]
26. Immunization with PfEMP1-DBL1alpha generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes.
Chen Q; Pettersson F; Vogt AM; Schmidt B; Ahuja S; Liljeström P; Wahlgren M
Vaccine; 2004 Jul; 22(21-22):2701-12. PubMed ID: 15246600
[TBL] [Abstract][Full Text] [Related]
27. A possible key molecule for the invasion of the Plasmodium berghei ookinetes into the midgut epithelium of Anopheles gambiae mosquitoes.
Toubarro DN; Ralha D; Carvalho S; Tomás AM; Almeida AP
In Vivo; 2010; 24(3):271-80. PubMed ID: 20554998
[TBL] [Abstract][Full Text] [Related]
28. Food vacuole targeting and trafficking of falcipain-2, an important cysteine protease of human malaria parasite Plasmodium falciparum.
Dasaradhi PV; Korde R; Thompson JK; Tanwar C; Nag TC; Chauhan VS; Cowman AF; Mohmmed A; Malhotra P
Mol Biochem Parasitol; 2007 Nov; 156(1):12-23. PubMed ID: 17698213
[TBL] [Abstract][Full Text] [Related]
29. A study on pathogenicity and mosquito transmission success in the rodent malaria parasite Plasmodium chabaudi adami.
Gadsby N; Lawrence R; Carter R
Int J Parasitol; 2009 Feb; 39(3):347-54. PubMed ID: 18755194
[TBL] [Abstract][Full Text] [Related]
30. Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria Parasites.
Low LM; Ssemaganda A; Liu XQ; Ho MF; Ozberk V; Fink J; Sundac L; Alcorn K; Morrison A; O'Callaghan K; Gerrard J; Stanisic DI; Good MF
Infect Immun; 2019 Jan; 87(1):. PubMed ID: 30323025
[TBL] [Abstract][Full Text] [Related]
31. Acute Plasmodium chabaudi chabaudi malaria infection induces antibodies which bind to the surfaces of parasitized erythrocytes and promote their phagocytosis by macrophages in vitro.
Mota MM; Brown KN; Holder AA; Jarra W
Infect Immun; 1998 Sep; 66(9):4080-6. PubMed ID: 9712751
[TBL] [Abstract][Full Text] [Related]
32. Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.
Mehrizi AA; Zakeri S; Rafati S; Salmanian AH; Djadid ND
Parasite Immunol; 2011 Nov; 33(11):594-608. PubMed ID: 21883290
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the spleen B-cell compartment at the early and late blood-stage Plasmodium chabaudi malaria.
Castillo-Méndez SI; Zago CA; Sardinha LR; Freitas do Rosário AP; Alvarez JM; D'Império Lima MR
Scand J Immunol; 2007; 66(2-3):309-19. PubMed ID: 17635808
[TBL] [Abstract][Full Text] [Related]
34. Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of homologous and heterologous antigen-delivery prime-boost strategy.
Kongkasuriyachai D; Bartels-Andrews L; Stowers A; Collins WE; Sullivan J; Sattabongkot J; Torii M; Tsuboi T; Kumar N
Vaccine; 2004 Aug; 22(23-24):3205-13. PubMed ID: 15297075
[TBL] [Abstract][Full Text] [Related]
35. Immunization of mice with Escherichia coli containing an antigen of the malaria parasite Plasmodium chabaudi chabaudi expressed in lambda gt11 induces high antibody titres.
Hartz D; Langhorne J
Immunol Lett; 1994 Jul; 41(2-3):217-23. PubMed ID: 8002041
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of C3d on the immunogenicity of gene gun vaccines encoding Plasmodium falciparum and Plasmodium berghei MSP1(42).
Weiss R; Gabler M; Jacobs T; Gilberger TW; Thalhamer J; Scheiblhofer S
Vaccine; 2010 Jun; 28(28):4515-22. PubMed ID: 20438877
[TBL] [Abstract][Full Text] [Related]
37. Plasmodium berghei XAT: protective 155/160 kDa antigens are located in parasitophorous vacuoles of schizont-stage parasite.
Kobayashi F; Waki S; Niikura M; Tachibana M; Tsuboi T; Torii M; Kamiya S
Exp Parasitol; 2007 Aug; 116(4):450-7. PubMed ID: 17442306
[TBL] [Abstract][Full Text] [Related]
38. A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice.
Gentil F; Bargieri DY; Leite JA; Françoso KS; Patricio MB; Espíndola NM; Vaz AJ; Palatnik-de-Sousa CB; Rodrigues MM; Costa FT; Soares IS
Vaccine; 2010 Aug; 28(38):6183-90. PubMed ID: 20654667
[TBL] [Abstract][Full Text] [Related]
39. Anti-Thy-1 treated and irradiated spleen cells from (BALB/c x C57Bl/6) F1 mice infected with Plasmodium chabaudi chabaudi can transfer protection into irradiated hosts.
Legorreta-Herrera M; Fiallos-Leon C; Cedillo-Barron L; Martinez-Gomez F; Foster-Cuevas M; Favila-Castillo L
Parasite Immunol; 1993 Mar; 15(3):143-51. PubMed ID: 8316408
[TBL] [Abstract][Full Text] [Related]
40. Plasticity of immune responses suppressing parasitemia during acute Plasmodium chabaudi malaria.
Weidanz WP; Kemp JR; Batchelder JM; Cigel FK; Sandor M; Heyde HC
J Immunol; 1999 Jun; 162(12):7383-8. PubMed ID: 10358190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
